 Regression left ventricular hypertrophy partial correction anemia erythropoietin patients hemodialysis prospective study Myocardial effects recombinant human erythropoietin rhEPO treatment hemodialysis HD patients severe anemia hematocrit Ht Echocardiographic studies midweek HD session year rhEPO end study period Ht cardiac index vs Left ventricular mass index LVMi rhEPO vs decrease concomitant decrease LV end-diastolic diameter vs cm interventricular septum thickness IVST vs cm LV wall thickness LVPWT vs cm patients hypertensive hypotensive drugs group normotensive group II LVMi group group II rhEPO vs rhEPO groups LVMi group group II end study vs elevated IVST/LVPWT year rhEPO vs correction asymmetric septal hypertrophy ventricular hypertrophy LVH regression partial correction anemia rhEPO Previous hypertension current need antihypertensive treatment significant effect development LVH Whether regression outcome HD patients